"Inverse Vaccine" As a Potential Treatment of Autoimmune Disease
In a recent publication in the journal Nature Biomedical Engineering, researchers from the Univsersity of Chicago introduced a new concept of an "Inverse Vaccine" as a potential treatment tool for autoimmune disease. This new type of treatment essentially removes the immune systems memory of specific molecules. This concept is based on the immune system's natural "do-not destroy" marking of normal cell components which undergo normal cell death. Tagging molecules with a sugar known as N-acetylgalactosamine (pGal) could mimic this process and prevent immune recognition. The in-virto proof of concept study was performed on a Multiple Sclerosis model. Initial human safety trials have been conducted for Celiac Disease. Further trials of pGal compounds are planned.
Search our Directory
AABRM Members are not only experts in regenerative medicine but offer a wide range of related products, services and related-procedures in that field. Search our extensive Member Directory to find a Member near you.Member Directory